CVRx, Inc. (CVRX) News
Follow CVRx, Inc. (CVRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
CVRx Reports Q3 Revenue of $13.8 Million, Updates 2026 Guidance
CVRx reported third-quarter revenue of $13.8 million, including $13.0 million in U.S. revenue. It raised its full-year 2026 revenue guidance to $56 million–$57 million.
EQUITY | Nov 06, 2026, 02:06 PM UTC
L
CVRx 3Q 2026: Revenue $13.83M, EPS ($0.52) — 10-Q Summary
CVRx revenue declined 6% year over year in the third quarter, while its net loss widened. Lower U.S. sales force productivity and prolonged reimbursement challenges with a large payer weighed on revenue; lower manufactur
EARNINGS | Nov 05, 2026, 09:51 PM UTC
H
CVRx Reports Q2 2026 Results: Full Earnings Call Transcript
On Thursday, CVRx (NASDAQ: CVRX ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts
LIVE | Oct 12, 2026, 11:03 AM UTC
H
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
MINNEAPOLIS, Sept. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. NASDAQ:CVRX, a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascu
NEWS | Sep 29, 2026, 08:32 PM UTC
L
CVRX - CVRx Appoints John Landry as Chief Financial Officer
CVRX - CVRx Appoints John Landry as Chief Financial Officer
NEWS | Sep 21, 2026, 08:07 PM UTC
L
CVRx responds to letter from Pointillist Family Office
CVRx says it is responding to a letter from the Pointillist Family Office, according to TradeXchange Newsdesk.
EQUITY | Aug 25, 2026, 12:02 PM UTC
L
CVRX announces Dedicated Health Medicare Advantage coverage policy for Barostim therapy
CVRX says it has announced a Dedicated Health Medicare Advantage coverage policy for Barostim therapy.
REGULATION | Aug 24, 2026, 12:31 PM UTC
H
Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket
Shares of Atlassian Corp (NASDAQ: TEAM ) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results. Atlassian reported fourth-quarter revenue of $1.766 billion, u
EARNINGS | Aug 07, 2026, 08:33 AM UTC
H
CVRx Stock Is Falling Overnight: Here's What's Driving the Move
CVRx Inc. (NASDAQ: CVRX ) shares plunged more than 45% after the company slashed its full-year revenue outlook despite reporting double-digit sales growth during the second quarter. The stock closed Thursday’s regular se
EARNINGS | Aug 07, 2026, 05:42 AM UTC
L
CVRx Lowers FY2026 Sales Guidance from $63.000M-$67.000M to $58.000M-$60.000M vs $65.340M Est
CVRx (NASDAQ: CVRX ) lowers FY2026 sales outlook from $63.000 million-$67.000 million to $58.000 million-$60.000 million vs $65.340 million estimate.
EARNINGS | Aug 06, 2026, 08:32 PM UTC